tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NERV Stock Latest News

Minerva Neurosciences Reports Q1 2025 Earnings and Regulatory Challenges
Company AnnouncementsMinerva Neurosciences Reports Q1 2025 Earnings and Regulatory Challenges
23d ago
NERV
Minerva reports Q1 EPS (50c) vs ($1.13) last year
PremiumThe Fly
Minerva reports Q1 EPS (50c) vs ($1.13) last year
2M ago
NERV
NERV Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NERV Earnings this Week: How Will it Perform?
2M ago
NERV
Minerva Neurosciences Reports Improved 2024 Financials
PremiumCompany Announcements
Minerva Neurosciences Reports Improved 2024 Financials
4M ago
NERV
Hold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints
PremiumRatings
Hold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints
4M ago
NERV
Minerva reports Q4 EPS (56c) vs. ($1.19) last year
PremiumThe FlyMinerva reports Q4 EPS (56c) vs. ($1.19) last year
4M ago
NERV
Minerva Neurosciences Reports Positive Earnings Amid FDA Challenges
Premium
Company Announcements
Minerva Neurosciences Reports Positive Earnings Amid FDA Challenges
8M ago
NERV
Minerva reports Q3 EPS $2.97 vs. ($1.03) last year
Premium
The Fly
Minerva reports Q3 EPS $2.97 vs. ($1.03) last year
8M ago
NERV
Is NERV a Buy, Before Earnings?
PremiumPre-Earnings
Is NERV a Buy, Before Earnings?
8M ago
NERV
Minerva price target lowered to $5 from $7 at H.C. Wainwright
PremiumThe Fly
Minerva price target lowered to $5 from $7 at H.C. Wainwright
11M ago
NERV
Minerva reports Q EPS ($1.09) vs ($1.12 ) last year
PremiumThe Fly
Minerva reports Q EPS ($1.09) vs ($1.12 ) last year
11M ago
NERV
NERV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
NERV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11M ago
NERV
Minerva Neurosciences Announces Board and Audit Committee Changes
PremiumCompany AnnouncementsMinerva Neurosciences Announces Board and Audit Committee Changes
1y ago
8K
NERV
Minerva price target lowered to $7 from $11 at H.C. Wainwright
Premium
The Fly
Minerva price target lowered to $7 from $11 at H.C. Wainwright
1y ago
NERV
Minerva reports Q1 EPS ($1.13) vs ($1.31) last year
Premium
The Fly
Minerva reports Q1 EPS ($1.13) vs ($1.31) last year
1y ago
NERV
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
ALT
CTMX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
ALT
CTMX
Minerva trading resumes
PremiumThe Fly
Minerva trading resumes
1y ago
NERV
Minerva trading halted, volatility trading pause
PremiumThe Fly
Minerva trading halted, volatility trading pause
1y ago
NERV
Minerva receives complete response letter from FDA for NDA for roluperidone
PremiumThe FlyMinerva receives complete response letter from FDA for NDA for roluperidone
1y ago
NERV
Minerva reports Q4 EPS ($1.19) vs. ($1.26) last year
Premium
The Fly
Minerva reports Q4 EPS ($1.19) vs. ($1.26) last year
1y ago
NERV
Minerva reports Q3 EPS ($1.03) vs. ($1.29) last year
Premium
The Fly
Minerva reports Q3 EPS ($1.03) vs. ($1.29) last year
2y ago
NERV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >